Evidence map›Paper›PMID 31965418›Full record

ArticleJournal of clinical immunology2020

T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.

Stephanie Heller, Uwe Kölsch, Thomas Magg, Renate Krüger, Andrea Scheuern, Holm Schneider, Anna Eichinger, Volker Wahn, Nadine Unterwalder, Myriam Lorenz and 5 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Journal of clinical immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 1 country.

Stephanie HellerDepartment of Pediatric Pulmonology, Immunology, and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Uwe KölschDepartment of Immunology, Labor Berlin GmbH, Berlin, Germany.
Thomas MaggDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital LMU, Munich, Germany.
Renate KrügerDepartment of Pediatric Pulmonology, Immunology, and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Andrea ScheuernDepartment of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
Holm SchneiderCenter for Ectodermal Dysplasias and Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.
Anna EichingerDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital LMU, Munich, Germany.
Volker WahnDepartment of Pediatric Pulmonology, Immunology, and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Nadine UnterwalderDepartment of Immunology, Labor Berlin GmbH, Berlin, Germany.
Myriam LorenzInstitute for Transfusion Medicine, University of Ulm, Ulm, Germany.
Klaus SchwarzInstitute for Transfusion Medicine, University of Ulm, Ulm, Germany.
Christian MeiselBerlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany.
Ansgar SchulzDepartment of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.
Fabian HauckDepartment of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital LMU, Munich, Germany.
Horst von BernuthDepartment of Pediatric Pulmonology, Immunology, and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Berlin, Germany. horst.von-bernuth@charite.de.ORCID 0000-0002-5812-7675
Berlin-Brandenburger Centrum für Regenerative Therapien · DELudwig-Maximilians-Universität München · DECharité - Universitätsmedizin Berlin · DEUniversität Ulm · DEUniversity Hospital Ulm · DEUniversitätsklinikum Erlangen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNEMO-deficient patients present with variable degrees of immunodeficiency. Accordingly, treatment ranges from antibiotic prophylaxis and/or IgG-substitution to allogenic hematopoietic stem cell transplantation (HSCT). The correct estimation of the immunodeficiency is essential to avoid over- as well as under-treatment. We compare the immunological phenotype of a NEMO-deficient patient with a newly-described splice site mutation that causes truncation of the NEMO zinc-finger (ZF) domain and a severe clinical course with the immunological phenotype of three NEMO-deficient patients with missense mutations and milder clinical courses and all previously published patients.

methodsLymphocyte subsets, proliferation, and intracellular NEMO-expression were assessed by FACS. NF-κB signal transduction was determined by measuring IκBα-degradation and the production of cytokines upon stimulation with TNF-α, IL-1β, and TLR-agonists in immortalized fibroblasts and whole blood, respectively.

resultsThe patient with truncated ZF-domain of NEMO showed low levels of IgM and IgG, reduced class-switched memory B cells, almost complete skewing towards naïve CD45RA

conclusionThe loss of the ZF-domain and the impaired T cell proliferation accompanied by almost complete persistence of naïve T cells despite severe infections are suggestive for a profound immunodeficiency. Allogenic HSCT should be considered early for these patients before chronic sequelae occur.

Indexed as

GenotypeAdultCell ProliferationCells, CulturedChild, PreschoolFemaleHumansI-kappa B KinaseImmunoglobulin GImmunologic Deficiency SyndromesImmunologic MemoryInfantMalePedigreePhenotypePrognosisI-kappa B KinaseIKBKG protein, humanImmunoglobulin GCD45RA+ naïve T cellsimmunological phenotypeNEMO deficiencyPrimary immunodeficiencyT cell deficiency

Identifiers

PMID31965418
OpenAlexW3000774164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.